Skip to Main

Chun Wu is the Managing Partner of BCG Greater China, leading the business in this region.

Since joining BCG, Chun has served various multinational and local healthcare clients on strategic and operational topics, covering healthcare reform impact and growth strategy; R&D, especially new technology platforms; commercial excellence and digital transformation; and organization change.

Currently, Chun dedicates significant time in big data and AI in healthcare. She also supports clients in healthcare and other industries on climate and sustainability through technology and business model innovations.

Prior to joining BCG, Chun was the co-founder and COO of iCarbonX, a healthcare big data and artificial intelligence company.

AREAS OF EXPERTISE

EDUCATION

  • PhD, Yale University
  • BS, Peking University

Publications and Videos

Synthetic Biology Industry Report

中国合成生物学产业白皮书2024

全球合成生物学产业正处在高速发展期，中国合成生物学产业虽然起步较晚，但发展势头强劲。本报告总结合成生物学产业发展的趋势，分析了合成生物学在生物医药、农业、食品与营养、消费个护、高性能材料、大宗化学品、生物能源等方向的应用，并对各细分行业的发展前景进行评估，旨在为相关领域的研究和实践提供有益的思考。
china-pathway-to-a-sustainable-future.jpg

China’s Pathway to a Sustainable Future: Enabling Social-minded Business and High-level Openness

Building a reality-anchored, future-proofed sustainable business ecosystem is a key lever to enable businesses to do good and elevate openness to the next level.
china-pathway-to-a-sustainable-future.jpg

中国可持续发展实践之路：助力商业向善及更高水平开放

打造可持续发展的商业生态是推动中国经济长期高质量向好发展的必要条件，是助力商业向善和更高水平开放的关键手段。
" "

New Drug Modalities Offer Promise and Peril

Gene therapy, stem cells, and other advances are changing the way complex diseases are treated. To capitalize, biopharma and biotech companies need to make strategic decisions about where to focus their efforts.
Competing in China’s Booming Biopharma Market - square

Competing in China’s Booming Biopharma Market

Multinational companies need to map a strategy to tap into China’s growth—and compete with increasingly innovative “homegrown” Chinese biopharma companies.
from-insight-to-action-1694x950-tcm9-74019.jpg

Capturing a Share of China’s Consumer Health Market

China’s growing market for health and wellness products presents an enormous opportunity for companies that understand Chinese consumers and how best to reach them.
new-rules-china-1694x950-tcm9-62895.jpg

New Rules for Winning in China’s Pharmaceutical Market

Powerful forces, including health care reform, are sweeping the pharmaceutical market in China, rewriting the rules for both multinational corporations and local companies.
new-rules-china-1694x950-tcm9-62895.jpg

New Rules for Winning in China’s Pharmaceutical Market

Powerful forces, including health care reform, are sweeping the pharmaceutical market in China, rewriting the rules for both multinational corporations and local companies.
2013-building-a-world-class-1116x626-tcm9-99396.jpg

Building a World-Class, Innovative Therapeutic Biologics Industry in China

Therapeutic biologics provide significant health benefits and address many unmet medical needs. China has the ambition—and potential—to build a world-class innovative biologics sector.
2012-pharmas-next-bill-1116x626-tcm9-98808.jpg

Pharma’s Next-Billion Patients

Pharmaceutical companies that can navigate China’s fast-emerging health-care markets—especially county hospitals and community health-care centers—will be well positioned to reach the industry's next-billion patients.